Rights and permissions
About this article
Cite this article
Cefpodoxime proxetil cost saving for recurrent pharyngotonsillitis. Pharmacoecon. Outcomes News 81, 7 (1996). https://doi.org/10.1007/BF03270309
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270309